PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsprostatitis
MeSH D011472 - prostatitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D011469:Prostatic diseases
0 Companies
0 Drugs
Success rate
D011472: 
Prostatitis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCiprofloxacin Ciprofloxacin  2004-06-09   
Ofloxacin Ofloxacin  2003-09-02   
Taro PharmaceuticalCiprofloxacin Ciprofloxacin  2004-10-06   
NATCO PharmaCiprofloxacin Ciprofloxacin  2004-06-09   
Johnson & JohnsonOfloxacin Floxin  1990-12-28   
SandozOfloxacin Ofloxacin  2004-05-14   
Ciprofloxacin Ciloxan  1990-12-31   
Hydrocortisone, Ciprofloxacin Cipro  1998-02-10   
Dexamethasone, Ciprofloxacin Ciprodex 2025-06-04 2003-07-18   
Bausch Health CompaniesOfloxacin Ofloxacin  2008-03-17   
AllerganOfloxacin Ocuflox  1993-07-30   
Ciprofloxacin Ciprofloxacin  2005-01-21   
BayerCiprofloxacin Cipro  1987-10-22   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
23%
3/13
Phase 2
22%
2/9
Phase 3
45%
5/11
Approved: 4Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
GSK
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use